The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...
Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...
The co-presenter of the Movers And Shakers podcast, about life with Parkinson’s and which has previously featured ... their ...
New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.
Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team ...
The Who star Pete Townshend has opened up about the “pain” Parkinson’s disease has caused for those close to him as he threw his support behind an upcoming charity album. At such a critical moment in ...
“I am talking about chronic pain, addiction, neurooncology ... treatment for movement disorders such as essential tremor and Parkinson’s disease. (Mike Stocker/South Florida Sun Sentinel ...